Literature DB >> 21799325

The evolution of oncology electronic health records.

Peter Paul Yu1.   

Abstract

Health information technology will transform health care delivery over the coming years. The central element of this will be the electronic health record, maintained by health professionals and linked to other health care providers, patients, and research and population health databases. Support of oncology functionality will necessitate special attention to how electronic health records are constructed, cancer-related data represented within, and clinical decision support tools designed to best support the objectives of quality care and cost-effectiveness. Standardization of functions and software will permit data exchange, leading to enhanced interoperability of systems. The present efforts at establishing oncology-related standards for electronic health records are reviewed.

Entities:  

Mesh:

Year:  2011        PMID: 21799325     DOI: 10.1097/PPO.0b013e3182269629

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  4 in total

Review 1.  Computerized prescriber order entry in the outpatient oncology setting: from evidence to meaningful use.

Authors:  V Kukreti; R Cosby; A Cheung; S Lankshear
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

Review 2.  Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.

Authors:  M J Rioth; J Warner; B N Savani; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

3.  Predictors and intensity of online access to electronic medical records among patients with cancer.

Authors:  David E Gerber; Andrew L Laccetti; Beibei Chen; Jingsheng Yan; Jennifer Cai; Samantha Gates; Yang Xie; Simon J Craddock Lee
Journal:  J Oncol Pract       Date:  2014-07-08       Impact factor: 3.840

4.  Patient portal adoption and use by hospitalized cancer patients: a retrospective study of its impact on adverse events, utilization, and patient satisfaction.

Authors:  Duaa Aljabri; Adrian Dumitrascu; M Caroline Burton; Launia White; Mahmud Khan; Sudha Xirasagar; Ronnie Horner; James Naessens
Journal:  BMC Med Inform Decis Mak       Date:  2018-07-27       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.